You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Realgar-Indigo Naturalis Formula, Retinoic Acid

Showing 1 - 25 of 8,979
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

Recruiting
  • Acute Myeloid Leukemia
  • All-trans retinoic acid
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022

Rhabdomyosarcoma, Child Trial (Realgar-Indigo Naturalis Formulation, Radiotherapy)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • Realgar-Indigo Naturalis Formulation
  • Radiotherapy
  • (no location specified)
Jan 31, 2023

Arsenic Trioxide, Childhood ALL Trial in Guangzhou (Realgar Indigo naturalis formula, Conventional chemo)

Recruiting
  • Arsenic Trioxide
  • Childhood ALL
  • Realgar Indigo naturalis formula
  • Conventional chemotherapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jan 10, 2023

Acute Promyelocytic Leukaemia Trial (Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid)

Not yet recruiting
  • Acute Promyelocytic Leukaemia
  • Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
  • (no location specified)
Nov 26, 2019

MDS Trial (Roxadustat in combination with retinoic acid)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Roxadustat in combination with retinoic acid
  • (no location specified)
Aug 26, 2023

Melanoma Trial in Aurora (VESANOID, Ipilimumab)

Active, not recruiting
Has Results
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
Sep 7, 2022

Patient Activation Trial in Moscow (PanTrek)

Not yet recruiting
  • Patient Activation
  • PanTrek
  • Moscow, Russian Federation
    Laboratory of psychopharmacology Research center of mental healt
Jan 10, 2023

ALDH1A1 Expression in Invasive Mammary Carcinoma

Enrolling by invitation
  • Breast Cancer
    • Sohag, Egypt
      Faculty of Medicine
    Nov 12, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 27, 2022

    Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

    Not yet recruiting
    • Breast Cancer
    • laboratory test (RAI14 and MACC-1 )
    • (no location specified)
    Oct 18, 2023

    Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

    Completed
    • Effect of Drug
    • Taichung, Please Select, Taiwan
      China Medical University Hospital
    Jul 28, 2022

    Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])

    Completed
    • Scalp Psoriasis
    • Tazarotene 0.045% Topical Application Lotion [ARAZLO]
    • Karachi, Sindh, Pakistan
      JPMC
    Aug 28, 2023

    Cow's Milk Protein Allergy Trial (Partially hydrolyzed formula)

    Not yet recruiting
    • Cow's Milk Protein Allergy
    • Partially hydrolyzed formula
    • (no location specified)
    Nov 11, 2023

    MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Tamibarotene + Azacitidine
    • Tamibarotene Matched Placebo + Azacitidine
    • Tucson, Arizona
    • +87 more
    Feb 2, 2023

    Children, Only Trial in Yogyakarta (Formula milk with triple Bifidobacterium probiotic strain, Formula milk)

    Active, not recruiting
    • Children, Only
    • Formula milk with triple Bifidobacterium probiotic strain
    • Formula milk
    • Yogyakarta, Special Region Of Yogyakarta, Indonesia
    • +9 more
    Sep 12, 2023

    Weight Gain Trial in Ancona, Padua (EX_IMF, ST_IMF)

    Recruiting
    • Weight Gain
    • EX_IMF
    • ST_IMF
    • Ancona, Italy
    • +1 more
    Jan 20, 2023

    Healthy Trial (Alcohol, Alcohol+protein, Alcohol+retinol)

    Not yet recruiting
    • Healthy
    • Alcohol
    • +3 more
    • (no location specified)
    Oct 25, 2023

    Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

    Recruiting
    • Acute Myeloid Leukemia
    • Tucson, Arizona
    • +8 more
    Jan 3, 2023

    Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)

    Recruiting
    • Solid Tumor, Adult
    • HF1K16 /Arm 45 mg/m2
    • +3 more
    • Shanghai, Shanghai, China
    • +2 more
    May 23, 2022

    APL Trial in Shanghai (Chidamide+venetoclax)

    Active, not recruiting
    • APL
    • Shanghai, Shanghai, China
      Jiong HU
    May 30, 2023

    Feeding Intolerance, Preterm Infants Trial in Chongqing (formula)

    Recruiting
    • Feeding Intolerance
    • Preterm Infants
    • formula
    • Chongqing, Chongqing, China
      Children's Hospital of Chongqing Medical University
    Apr 20, 2022

    Papilloma, Cervix Lesion Trial in Roma (Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid)

    Completed
    • Papilloma
    • Cervix Lesion
    • Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid
    • Roma, Italy
      Clinica Alma Res
    Dec 21, 2022

    Inherited Retinal Dystrophy Primarily Involving Sensory Retina Trial (Disulfiram 250 mg, Placebo)

    Not yet recruiting
    • Inherited Retinal Dystrophy Primarily Involving Sensory Retina
    • Disulfiram 250 mg
    • Placebo
    • (no location specified)
    Nov 22, 2022